It is already clear that Zeiss Convivo is a world class instrument that is seen in the Tumour Workflow model coupled with Kinevo for control and microscopic evaluation and an irradiation tool for treatment. Now we have an update with comments from the first users and an indication of Zeiss marketing at EANS 2019. See the parts of the videos under "Check" and "Impressions and first customer voices at EANS".
http://bit.ly/35A1Xtu
The technology is world class and now we know that Zeiss marketing is up to the task. As we long suffering shareholders know it will take time to convince the hospitals/institutions to purchase and install this very expensive equipment but it is becoming evident that Convivo is in a class of its own.
My sentiment has switched to "BUY".
Zeiss marketing in action
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $142.0M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 15.5¢ | $20.58K | 127.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14519 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 4702 | 1 |
View Market Depth
| Last trade - 13.51pm 13/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |